Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Systematic Evaluation of Sanger Validation of Next-Generation Sequencing Variants
by
Biesecker, Leslie G
, Mullikin, James C
, Beck, Tyler F
in
Animals
/ Deoxyribonucleic acid
/ Design
/ DNA
/ DNA - blood
/ DNA - genetics
/ Funding
/ Genes
/ Genetic testing
/ Genetic Variation - genetics
/ Genomes
/ Genomics
/ Genomics - methods
/ Genotype & phenotype
/ High-Throughput Nucleotide Sequencing - methods
/ High-Throughput Nucleotide Sequencing - standards
/ High-Throughput Nucleotide Sequencing - statistics & numerical data
/ Humans
/ Models, Statistical
/ Mutation
/ Sequence Analysis, DNA - methods
/ Sequence Analysis, DNA - standards
/ Sequence Analysis, DNA - statistics & numerical data
/ Studies
2016
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Systematic Evaluation of Sanger Validation of Next-Generation Sequencing Variants
by
Biesecker, Leslie G
, Mullikin, James C
, Beck, Tyler F
in
Animals
/ Deoxyribonucleic acid
/ Design
/ DNA
/ DNA - blood
/ DNA - genetics
/ Funding
/ Genes
/ Genetic testing
/ Genetic Variation - genetics
/ Genomes
/ Genomics
/ Genomics - methods
/ Genotype & phenotype
/ High-Throughput Nucleotide Sequencing - methods
/ High-Throughput Nucleotide Sequencing - standards
/ High-Throughput Nucleotide Sequencing - statistics & numerical data
/ Humans
/ Models, Statistical
/ Mutation
/ Sequence Analysis, DNA - methods
/ Sequence Analysis, DNA - standards
/ Sequence Analysis, DNA - statistics & numerical data
/ Studies
2016
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Systematic Evaluation of Sanger Validation of Next-Generation Sequencing Variants
by
Biesecker, Leslie G
, Mullikin, James C
, Beck, Tyler F
in
Animals
/ Deoxyribonucleic acid
/ Design
/ DNA
/ DNA - blood
/ DNA - genetics
/ Funding
/ Genes
/ Genetic testing
/ Genetic Variation - genetics
/ Genomes
/ Genomics
/ Genomics - methods
/ Genotype & phenotype
/ High-Throughput Nucleotide Sequencing - methods
/ High-Throughput Nucleotide Sequencing - standards
/ High-Throughput Nucleotide Sequencing - statistics & numerical data
/ Humans
/ Models, Statistical
/ Mutation
/ Sequence Analysis, DNA - methods
/ Sequence Analysis, DNA - standards
/ Sequence Analysis, DNA - statistics & numerical data
/ Studies
2016
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Systematic Evaluation of Sanger Validation of Next-Generation Sequencing Variants
Journal Article
Systematic Evaluation of Sanger Validation of Next-Generation Sequencing Variants
2016
Request Book From Autostore
and Choose the Collection Method
Overview
Next-generation sequencing (NGS) data are used for both clinical care and clinical research. DNA sequence variants identified using NGS are often returned to patients/participants as part of clinical or research protocols. The current standard of care is to validate NGS variants using Sanger sequencing, which is costly and time-consuming.
We performed a large-scale, systematic evaluation of Sanger-based validation of NGS variants using data from the ClinSeq® project. We first used NGS data from 19 genes in 5 participants, comparing them to high-throughput Sanger sequencing results on the same samples, and found no discrepancies among 234 NGS variants. We then compared NGS variants in 5 genes from 684 participants against data from Sanger sequencing.
Of over 5800 NGS-derived variants, 19 were not validated by Sanger data. Using newly designed sequencing primers, Sanger sequencing confirmed 17 of the NGS variants, and the remaining 2 variants had low quality scores from exome sequencing. Overall, we measured a validation rate of 99.965% for NGS variants using Sanger sequencing, which was higher than many existing medical tests that do not necessitate orthogonal validation.
A single round of Sanger sequencing is more likely to incorrectly refute a true-positive variant from NGS than to correctly identify a false-positive variant from NGS. Validation of NGS-derived variants using Sanger sequencing has limited utility, and best practice standards should not include routine orthogonal Sanger validation of NGS variants.
Publisher
Oxford University Press
Subject
/ Design
/ DNA
/ Funding
/ Genes
/ Genetic Variation - genetics
/ Genomes
/ Genomics
/ High-Throughput Nucleotide Sequencing - methods
/ High-Throughput Nucleotide Sequencing - standards
/ High-Throughput Nucleotide Sequencing - statistics & numerical data
/ Humans
/ Mutation
/ Sequence Analysis, DNA - methods
/ Sequence Analysis, DNA - standards
/ Sequence Analysis, DNA - statistics & numerical data
/ Studies
MBRLCatalogueRelatedBooks
Related Items
Related Items
This website uses cookies to ensure you get the best experience on our website.